LinkedIn Profile

Access Acceleron Pharma historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:xlrn 31472 Apr 21st, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 21st, 2024 03:29AM Apr 21st, 2024 03:29AM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 20th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 20th, 2024 12:35AM Apr 20th, 2024 05:51PM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 19th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 19th, 2024 04:52AM Apr 19th, 2024 04:52AM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 18th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 18th, 2024 01:31AM Apr 18th, 2024 07:11PM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 17th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 17th, 2024 04:31AM Apr 17th, 2024 03:38PM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 16th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 16th, 2024 12:21AM Apr 16th, 2024 11:54AM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 15th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 15th, 2024 05:07AM Apr 15th, 2024 05:35PM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 14th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 13th, 2024 11:55PM Apr 14th, 2024 11:53AM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 13th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 12th, 2024 11:46PM Apr 13th, 2024 12:20PM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology
nasdaq:xlrn 31472 Apr 12th, 2024 12:00AM Acceleron Pharma 18K 75.00 Open Apr 11th, 2024 11:54PM Apr 12th, 2024 09:16AM Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Open Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Open 128 Sidney Street Cambridge MA US 02139 Acceleron Pharma Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.